Literature DB >> 24773202

The gut microbiota and its role in the development of allergic disease: a wider perspective.

C E West1, M C Jenmalm, S L Prescott.   

Abstract

The gut microbiota are critical in the homoeostasis of multiple interconnected host metabolic and immune networks. If early microbial colonization is delayed, the gut-associated lymphoid tissues (GALT) fail to develop, leading to persistent immune dysregulation in mice. Microbial colonization has also been proposed as a major driver for the normal age-related maturation of both Th1 and T regulatory (Treg) pathways that appear important in suppressing early propensity for Th2 allergic responses. There is emerging evidence that resident symbionts induce tolerogenic gut-associated Treg cells and dendritic cells that ensure the preferential growth of symbionts; keeping pathogenic strains in check and constraining proinflammatory Th1, Th2, and Th17 clones. Some effects of symbionts are mediated by short-chain fatty acids, which play a critical role in mucosal integrity and local and systemic metabolic function and stimulate the regulatory immune responses. The homoeostatic IL-10/TGF-β dominated tolerogenic response within the GALT also signals the production of secretory IgA, which have a regulating role in mucosal integrity. Contrary to the 'sterile womb' paradigm, recent studies suggest that maternal microbial transfer to the offspring begins during pregnancy, providing a pioneer microbiome. It is likely that appropriate microbial stimulation both pre- and postnatally is required for optimal Th1 and Treg development to avoid the pathophysiological processes leading to allergy. Disturbed gut colonization patterns have been associated with allergic disease, but whether microbial variation is the cause or effect of these diseases is still under investigation. We are far from understanding what constitutes a 'healthy gut microbiome' that promotes tolerance. This remains a major limitation and might explain some of the inconsistency in human intervention studies with prebiotics and probiotics. Multidisciplinary integrative approaches with researchers working in networks, using harmonized outcomes and methodologies, are needed to advance our understanding in this field.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 24773202     DOI: 10.1111/cea.12332

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  55 in total

Review 1.  Immune-Microbiota Interactions: Dysbiosis as a Global Health Issue.

Authors:  Alan C Logan; Felice N Jacka; Susan L Prescott
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

2.  Probiotics modulate gut microbiota and health status in Japanese cedar pollinosis patients during the pollen season.

Authors:  Gaku Harata; Himanshu Kumar; Fang He; Kenji Miyazawa; Kazutoyo Yoda; Manabu Kawase; Akira Kubota; Masaru Hiramatsu; Samuli Rautava; Seppo Salminen
Journal:  Eur J Nutr       Date:  2016-07-13       Impact factor: 5.614

Review 3.  Modulation of Type 1 Diabetes Risk by the Intestinal Microbiome.

Authors:  Mikael Knip; Jarno Honkanen
Journal:  Curr Diab Rep       Date:  2017-09-23       Impact factor: 4.810

Review 4.  The respiratory microbiome and innate immunity in asthma.

Authors:  Yvonne J Huang
Journal:  Curr Opin Pulm Med       Date:  2015-01       Impact factor: 3.155

Review 5.  Developing Primary Intervention Strategies to Prevent Allergic Disease.

Authors:  Kristina Rueter; Aveni Haynes; Susan L Prescott
Journal:  Curr Allergy Asthma Rep       Date:  2015-07       Impact factor: 4.806

Review 6.  The role of the intestinal microbiota in type 1 diabetes mellitus.

Authors:  Mikael Knip; Heli Siljander
Journal:  Nat Rev Endocrinol       Date:  2016-01-04       Impact factor: 43.330

7.  Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization.

Authors:  Hana Kozakova; Martin Schwarzer; Ludmila Tuckova; Dagmar Srutkova; Elzbieta Czarnowska; Ilona Rosiak; Tomas Hudcovic; Irma Schabussova; Petra Hermanova; Zuzana Zakostelska; Tamara Aleksandrzak-Piekarczyk; Anna Koryszewska-Baginska; Helena Tlaskalova-Hogenova; Bozena Cukrowska
Journal:  Cell Mol Immunol       Date:  2015-03-23       Impact factor: 11.530

8.  Relationship between prenatal antibiotic use and asthma in at-risk children.

Authors:  Brittany Lapin; Julie Piorkowski; Dennis Ownby; Sally Freels; Noel Chavez; Eva Hernandez; Cynthia Wagner-Cassanova; Darlene Pelzel; Carmen Vergara; Victoria Persky
Journal:  Ann Allergy Asthma Immunol       Date:  2014-12-19       Impact factor: 6.347

Review 9.  Environmental factors and eosinophilic esophagitis.

Authors:  Elizabeth T Jensen; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2018-05-02       Impact factor: 10.793

Review 10.  The possible mechanisms of the human microbiome in allergic diseases.

Authors:  Kagan Ipci; Niyazi Altıntoprak; Nuray Bayar Muluk; Mehmet Senturk; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-26       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.